Drug Type DNA vaccine, Therapeutic vaccine |
Synonyms AR vaccine, pTVG-AR, MVI 118 + [1] |
Target |
Mechanism AR antagonists(Androgen Receptor antagonists), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Phase 2 | US | - | 10 Sep 2019 |
Metastatic castration-resistant prostate cancer | Phase 1 | US | 30 Jan 2022 | |
Metastatic Prostate Carcinoma | Phase 1 | US | 24 Aug 2015 |
NCT02411786 (ESMO2019) Manual | Phase 1 | 40 | frxnovbnuy(ivtjrmvsce) = none zqyzvqyano (sckjphdmor ) View more | Positive | 30 Sep 2019 |